Global-VPD-trends-and-emerging-vaccines_-what-Australian-providers-need-to-know-Dr-Sarah-McGuinness-9th-AIF-2025.pdf

1、Global vaccine preventable disease trends and emerging vaccines:what Australian providers need to know15:30Dr Sarah McGuinness Infectious Diseases Physician&Senior Research Fellow,Monash University&Alfred HealthIMMUNISATION FOR HEALTH AND LIFE MEETING9th Annual Immunisation Forum 2025Global VPD tren

2、ds and emerging vaccines:what Australian providers need to knowDr Sarah McGuinnesssarah.mcguinnessmonash.edu Recipient of research funding from the National Health and Medical Research Council(NHMRC),Royal Australasian College of Physicians(RACP),International Society of Travel Medicine(ISTM)Receive

3、 royalties for contributions to UpToDate(chapter author)and as author/editor of the Manual of Travel Medicine 4th Edition(Springer)Co-facilitate a paid short course,the Travel Medicine Masterclass,at Monash UniversityNo financial relationships with pharmaceutical companiesDisclosuresVaccine historyT

4、ime1796 Worlds first successful vaccine(Smallpox,Edward Jenner)1979 Smallpox eradicatedhttps:/www.who.int/news-room/spotlight/history-of-vaccination/a-brief-history-of-vaccination2025 Commercial vaccines against 25 diseasesGlobal VPD resurgence:challenges and innovationsAccess to vaccines remains un

5、equalVaccine hesitancy is on the riseCOVID-19 pandemic disrupted immunisation programs globallyNew era of vaccine innovation:mRNA platforms,novel delivery systemsTodays talkRapid-fire tour of nine VPDs relevant to travellers Influenza Measles Mpox Dengue Chikungunya Tick-borne encephalitis Hepatitis

6、 A Typhoid PolioPerson to personFaecal-oral/environmentalVector-borneInfluenza epidemiology WHO Global Influenza Programme data:https:/www.who.int/teams/global-influenza-programme/surveillance-and-monitoring/influenza-surveillance-outputs Border closures and lockdowns(NPIs)Resurgence since 2023Influ